CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance.

Michael D Rosenblum; Edit Olasz; Jeffery E Woodliff; Bryon D Johnson; Marja C Konkol; Kimberly A Gerber; Rimas J Orentas; Gordon Sandford; Robert L Truitt

doi:10.1182/blood-2003-09-3184

CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance.

Identifier:nobleid.org/w1/20260515/C4F2CF9A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C4F2CF9A.svg?ark=w1%2F20260515%2FC4F2CF9A)](https://nobleid.org/work/w1/20260515/C4F2CF9A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance.

Identifier:nobleid.org/w1/20260515/C4F2CF9A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C4F2CF9A.svg?ark=w1%2F20260515%2FC4F2CF9A)](https://nobleid.org/work/w1/20260515/C4F2CF9A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work